Jian-Sheng Lin Selected Research

Jian-Sheng Lin Research Topics

Disease

10	Narcolepsy 01/2021 - 04/2008
7	Cataplexy 01/2022 - 04/2008
5	Sleepiness 04/2016 - 04/2008
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2011
4	Disorders of Excessive Somnolence (Hypersomnia) 01/2018 - 04/2008
3	Obesity 04/2016 - 12/2004
3	Sleep Wake Disorders 01/2016 - 12/2004
2	Sudden Infant Death (SID) 01/2022 - 01/2017
2	Dyskinesias (Dyskinesia) 01/2021 - 03/2011
2	Mouth Neoplasms (Oral Cancer) 11/2016 - 09/2014
1	Motor Disorders 01/2021
1	Restless Legs Syndrome (Restless Legs) 01/2021
1	Brain Injuries (Brain Injury) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Sleep Deprivation 01/2019
1	Postpartum Depression (Post-Natal Depression) 01/2017
1	Neoplasms (Cancer) 11/2016
1	Hypoventilation 04/2016
1	Respiratory Acidosis 04/2016
1	Pain (Aches) 12/2014
1	Squamous Cell Carcinoma of Head and Neck 09/2014
1	Parkinsonian Disorders (Parkinsonism) 11/2012
1	Influenza in Birds (Avian Flu) 03/2012
1	Cholestasis 01/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2012
1	Gallstones (Gallstone) 01/2012
1	Obstructive Sleep Apnea 04/2011
1	Schizophrenia (Dementia Praecox) 04/2007
1	Epilepsy (Aura) 12/2004
1	Cognitive Dysfunction 12/2004

Drug/Important Bio-Agent (IBA)

9	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 12/2004
6	OrexinsIBA 01/2021 - 04/2008
3	Modafinil (Provigil)FDA Link 01/2018 - 03/2012
3	Histamine H3 Receptors (Histamine H3 Receptor)IBA 02/2014 - 12/2004
3	pitolisantIBA 03/2012 - 04/2007
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022 - 01/2019
2	tele-methylhistamineIBA 01/2022 - 01/2019
2	NeuropeptidesIBA 01/2021 - 04/2008
2	Levodopa (L Dopa)FDA LinkGeneric 01/2021 - 03/2011
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 03/2012 - 12/2004
1	A-factor (Streptomyces)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2019
1	benzyl isothiocyanateIBA 11/2016
1	Bicarbonates (Hydrogen Carbonate)IBA 04/2016
1	Flecainide (Tambocor)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2014
1	Capsaicin (Zostrix)FDA Link 12/2014
1	acetovanillone (apocynin)IBA 09/2014
1	TEMPOIBA 09/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 09/2014
1	CatalaseIBA 09/2014
1	phenethyl isothiocyanate (PEITC)IBA 09/2014
1	Dopamine (Intropin)FDA LinkGeneric 11/2012
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2012
1	NeurotoxinsIBA 11/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2012
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 03/2012
1	Hemagglutinins (Hemagglutinin)IBA 03/2012
1	Mazindol (Mazanor)FDA Link 03/2012
1	Methylphenidate (Ritalin)FDA LinkGeneric 03/2012
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 03/2012
1	AutoreceptorsIBA 03/2012
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2012
1	Hypnotics and Sedatives (Sedatives)IBA 01/2012
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 04/2009
1	LigandsIBA 12/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2012
1	Transplantation 01/2020
1	Cesarean Section (Caesarean Section) 01/2017
1	Injections 12/2014
1	Off-Label Use 03/2012
1	Continuous Positive Airway Pressure 04/2011
1	Drug Therapy (Chemotherapy) 04/2011